Powered Surgical Instrument Market Size, Share, Opportunities, And Trends By Power Source (Electric Instruments, Battery-Powered Instruments, Pneumatic Instruments), By Product (Handpieces, Power Source & Controls, Accessories), By Application (Orthopedic Surgery, Oral And Maxillofacial Surgery, Neurosurgery, ENT Surgery, Cardiothoracic Surgery, Plastic And Reconstructive Surgery), And By Geography - Forecasts From 2024 To 2029

The powered surgical instruments market is anticipated to expand at a high CAGR over the forecast period.

It is a piece of precision equipment, buzzing with power, assisting surgeons in complex procedures with elegance and efficiency. These devices are the high-tech heroes of surgery, using electricity or batteries to deliver regulated and precise movements. Drills and saws improve orthopaedic treatments, whereas shavers and resection devices help in soft tissue surgery. The beauty resides in the increased capabilities, which enable surgeons to negotiate complications with ease.

Furthermore, with technological advances, we may expect a symphony of changes, including better ergonomic designs for comfort and smarter instruments that deliver real-time data and feedback. It's an exciting blend of medicine and technology, ensuring surgeries are coordinated shows of skill and invention rather than simply procedures.

Factors driving market expansion include an increase in the number of surgeries, advancements in less invasive techniques, and a quest for better surgical results. Powered surgical instruments include drills and saws for orthopedic treatments, as well as shavers and resection devices for soft tissue surgery.

Market Drivers

• Demand for surgical procedures is anticipated to propel the market growth.

A variety of variables are driving an increase in the number of surgical procedures performed. As the world's population ages and chronic diseases become more prevalent, the need for surgical procedures has increased significantly. Advances in medical knowledge, combined with a growing awareness of the benefits of surgical treatments, contribute to an increase in the number of procedures performed globally. Furthermore, increased healthcare accessibility and a better understanding of various medical conditions lead to a greater willingness among people to undergo surgical treatments.

The growing availability of sophisticated surgical procedures and technologies accelerates this upward trend, providing patients and surgeons with a broader choice of alternatives for addressing medical difficulties. According to a report by NCBI in 2023, by 2025, there are expected to be roughly 30,760 practicing general surgeons, with a demand of 33,730 surgeons. Several factors contribute to the obstacles that rural patients encounter in accessing important and regular procedures. In addition to existing health disparities, the declining number of surgeons is of particular concern as it significantly impacts both rural and metropolitan areas. By 2032, it is expected that there will be a shortage of around 23,000 surgeons in the United States.

•  The requirement for Minimally Invasive Surgery (MIS) is expected in the growth of the powered surgical instrument

The medical intervention paradigm is shifting dramatically, with a significant increase in demand for minimally invasive surgery (MIS). Both patients and healthcare providers recognize the numerous benefits that MIS provides. MIS, with its smaller incisions, allows for speedier recovery periods, less postoperative pain, and shorter hospital stays than standard open operations. Technological improvements, such as high-definition cameras and robotic-assisted systems, help to improve precision and visualization, making MIS a more popular alternative.

Patients who are well-informed and aware of aesthetic outcomes are driving increasing demand, attracted to the cosmetic benefits of reduced scars. Beyond its appeal, MIS has evolved into a versatile methodology that can be used in a wide range of medical specializations, providing efficient and cost-effective solutions. In terms of short-term outcomes, MIS-based procedures outperform identical open procedures. Furthermore, while early start-up costs may be higher with the use of MIS approaches in some cases when evaluating the whole cost of linked care, current research suggests that overall cost reductions may be realized. Percutaneous and endoscopic surgery may result in even greater cost savings.

• Technological advancements are expected to occur in the future.

Technological advances in powered surgical instruments have ushered in a new era of precision and efficiency in the operating theatre. These devices are more than just mechanical tools; they are intelligent, responsive, and precisely tailored to the demands of surgeons and patients. The integration of sensors and real-time feedback mechanisms provides surgeons with useful data during surgeries, which improves decision-making.

Precision engineering guarantees controlled and exact movements, which is essential in delicate surgeries. Miniaturization makes these instruments more versatile and adaptable to minimally invasive operations, reducing harm to surrounding tissues. The combination of powered instruments and robotics is changing surgical landscapes, providing more dexterity and accuracy. Improved power sources, enhanced visualization via high-definition cameras, and configurable ergonomic designs all contribute to a smooth surgical experience.

Robotic surgery (RS) is a progression of minimally invasive surgery that blends medical science, robotics, and engineering. The Food and Drug Administration (FDA) approved the first robots, the Da Vinci Surgical System and the ZEUS Robotic Surgical System, which have since improved. Over the decades, the equipment used in RS has undergone significant alteration in response to the development of new techniques and facilities for the assembly and implementation of their own. RS has transformed urology and many other surgical specialties, allowing surgeons to conduct complicated procedures with better precision and accuracy.

Asia Pacific Market is expected to grow significantly.

Asia Pacific is predicted to see the fastest growth rate in the powered surgical instruments market during the forecast period, owing to increased healthcare expenditure by the population and increasing adoption rate of powered surgical tools with robotic technology by hospitals and clinicians.

In Feb 2023, Japanese firm Asensus Surgical debuted Luna, its next-generation surgical robot platform. Asensus created Luna as a comprehensive digital surgery solution. It includes next-generation surgical platforms and devices, as well as real-time intraoperative clinical intelligence. The third component, a secure cloud platform, uses machine learning to provide clinical insights.

Market Restraints

• High initial costs could hinder market growth.

The high initial costs associated with the powered surgical equipment market represent a significant barrier to entrance and adoption for healthcare organizations. The advanced technology built into these instruments, particularly those integrating robotics, adds significantly to the initial costs. Hospitals and healthcare facilities must make significant financial investments to acquire these cutting-edge instruments, which might have an impact on budget allocations and potentially limit access for institutions with budgetary constraints.

Market Developments

• January 2024- Teflex Incorporated, a leading global manufacturer of medical technology, announced that the Titan SGS™ Stapler, the first purpose-built stapler for gastric tissue with a specific indication for sleeve pouch construction in bariatric procedures1, is now available with staple line reinforcement (SLR). This novel approach allows bariatric surgeons to buttress each staple during sleeve gastrectomy.
• November 2023- Johnson & Johnson MedTech announced intentions to submit the OTTAVA robotic surgical system for an experimental device exemption (IDE) application to the United States Food and Drug Administration (FDA) in the second half of 2024 to begin clinical trials. OTTAVA combines four robotic arms into a standard-sized surgery table. This unified architecture enables an undetectable design, with the robotic arms accessible when needed and stowed beneath the operating table when not. The design reduces obstacles to movement and communication in robotic operating rooms, giving surgical teams the freedom and flexibility to adapt to clinical procedures and specific patient demands.
• September 2023- Galen Robotics, Inc., a leading MedTech company specializing in sophisticated robotic surgical systems, received a De Novo classification award and authority to sell the Galen ES® Robotic System for stiff microlaryngeal procedures from the US Food and Drug Administration (FDA). This remarkable success advances Galen Robotics' objective to target neglected markets with their surgical robotic helper.

Segmentation

• By Power Source            
  • Electric Instruments
  • Battery-Powered Instruments
  • Pneumatic Instruments
• By Product
  • Handpieces
  • Power Source & Controls
  • Accessories
• By Application
  • Orthopedic Surgery
  • Oral and Maxillofacial Surgery
  • Neurosurgery
  • ENT Surgery
  • Cardiothoracic Surgery
  • Plastic and Reconstructive Surgery
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others